Sora Fallaha

Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors

Luqman Jubair, Sora Fallaha, Nigel A.J. McMillan · Molecular Therapy · 2019 · 100 citations · Full text

CRISPR/Cas9-loaded stealth liposomes effectively cleared established HPV16-driven tumours in syngeneic mice

Luqman Jubair, Alfred K. Lam, Sora Fallaha et al. · PLoS ONE · 2021 · 45 citations · Full text

Cause Cell Death, Immunology, Molecular Biology +20

Aurora A Is Critical for Survival in HPV-Transformed Cervical Cancer

Brian Gabrielli, Fawzi Bokhari, Max V. Ranall et al. · Molecular Cancer Therapeutics · 2015 · 40 citations · Full text

Apoptosis, Gynecology, Pathology +18

Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers

Mushfiq Hassan Shaikh, Adi Idris, Newell W. Johnson et al. · Oral Oncology · 2018 · 34 citations

Hpv-positive Head, Receptor Tyrosine Kinase, Novel Therapeutic Target +9

Inhibition of Aurora A and Aurora B Is Required for the Sensitivity of HPV-Driven Cervical Cancers to Aurora Kinase Inhibitors

David Martin, Sora Fallaha, Martina Proctor et al. · Molecular Cancer Therapeutics · 2017 · 23 citations · Full text